Julie Shimer - Avanos Medical Independent Director

AVNS Stock  USD 18.69  0.15  0.81%   

Director

Dr. Julie A. Shimer, Ph.D. serves as Independent Director of the Company. Dr. Shimer is the Chairman of the Compensation Committee. She is currently a private investor and has 30 years of product development experience, including many years with major communications companies. From March 2007 to April 2012 she served as Chief Executive Officer of Welch Allyn, Inc., a manufacturer of frontline medical products and solutions, having served on the board of directors beginning in July 2002. Previously, Dr. Shimer was President, Chief Executive Officer, and a member of the board of directors of Vocera Communications, Inc., a provider of wireless communications systems. She also has served as general manager at 3Com Corporation and Motorola and was a product development leader at Motorola and ATT Bell Laboratories. She has served as the Chairwoman of Empire State Development Corporationration, the State of New Yorks economic development organization, and as an advisor to two private companies, Kitchology, a mobile platform empowering families dealing with special diets through the power of technology and community, and CPLANE Networks, a leader in endtoend data center and wide area network service orchestration that enables softwaredefined networking and network function virtualization services to be launched and managed in a single environment. She also serves on the boards of directors of three nonprofit organizations. Dr. Shimer serves as a director of Netgear, Inc., a provider of home and small business network solutions, Windstream Holdings, Inc., a leading telecommunications and cloud services provider, and Apollo Endosurgery, Inc., a medical device company focused on less invasive therapies for the treatment of obesity, and Masimo Corporationrationration, a medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies. since 2014.
Age 68
Tenure 10 years
Address 5405 Windward Parkway, Alpharetta, GA, United States, 30004
Phone844 428 2667
Webhttps://avanos.com

Julie Shimer Latest Insider Activity

Tracking and analyzing the buying and selling activities of Julie Shimer against Avanos Medical stock is an integral part of due diligence when investing in Avanos Medical. Julie Shimer insider activity provides valuable insight into whether Avanos Medical is net buyers or sellers over its current business cycle. Note, Avanos Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Avanos Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Avanos Medical Management Efficiency

The company has return on total asset (ROA) of 0.0208 % which means that it generated a profit of $0.0208 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0177 %, meaning that it created $0.0177 on every $100 dollars invested by stockholders. Avanos Medical's management efficiency ratios could be used to measure how well Avanos Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (0.09). At this time, Avanos Medical's Total Current Assets are comparatively stable compared to the past year. Intangibles To Total Assets is likely to gain to 0.63 in 2024, whereas Net Tangible Assets are likely to drop slightly above 181.9 M in 2024.
Avanos Medical currently holds 209.1 M in liabilities with Debt to Equity (D/E) ratio of 0.24, which may suggest the company is not taking enough advantage from borrowing. Avanos Medical has a current ratio of 2.83, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Avanos Medical's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Joel SuiterSurModics
N/A
Aimee WeisnerGlaukos Corp
51
Michael DeManeNevro Corp
63
Shawn McCormickNevro Corp
56
Jean HobbyInteger Holdings Corp
60
Cheryl BlanchardAnika Therapeutics
60
Fred HiteOrthopediatrics Corp
56
Martha AronsonCONMED
53
James HinrichsInteger Holdings Corp
53
David BronsonCONMED
67
Gilbert KlimanGlaukos Corp
61
Jerome LandeCONMED
45
Charles FarkasCONMED
68
Jeffrey BurbankArtivion
58
Brian ConcannonCONMED
62
Kevin OBoyleNevro Corp
62
Donald SpenceInteger Holdings Corp
67
Frank FischerNevro Corp
78
Pamela BaileyInteger Holdings Corp
72
Alvin JeffersInteger Holdings Corp
47
David HoffmeisterGlaukos Corp
66
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Avanos Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 4555 people. Avanos Medical (AVNS) is traded on New York Stock Exchange in USA. It is located in 5405 Windward Parkway, Alpharetta, GA, United States, 30004 and employs 3,771 people. Avanos Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Avanos Medical Leadership Team

Elected by the shareholders, the Avanos Medical's board of directors comprises two types of representatives: Avanos Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avanos. The board's role is to monitor Avanos Medical's management team and ensure that shareholders' interests are well served. Avanos Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avanos Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Cato, Vice Resources
S Mansbach, Senior Vice President Interim General Counsel, Corporate Secretary
William Haydon, Senior Vice President and General Manager, Pain Management
Moji James, Senior Vice President General Counsel
Patrick OLeary, Independent Director
Sigfrido Delgado, Senior Chain
Julie Shimer, Independent Director
Michelle Scharfenberg, Senior Vice President Chief Ethics and Compliance Officer
Gary Blackford, Independent Non-Executive Chairman of the Board
William Hawkins, Independent Director
David Ball, Senior Vice President - Global Supply Chain and Procurement
Mojirade James, Senior Vice President General Counsel, Corporate Secretary
Heidi Kunz, Independent Director
Lee Burnes, Clinical RD
Michael Greiner, Chief Financial Officer, Senior Vice President
Scott Galovan, Vice Development
Michael CPA, Senior CEO
Sudhakar Varshney, Senior Procurement
John Byrnes, Independent Director
Maria Sainz, Independent Director
David Crawford, VP Treasurer
Arjun Sarker, Senior Vice President - International
John Hurley, Principal Controller
Kerr Holbrook, Senior Vice President General Manager - Chronic Care
Joseph Woody, Chief Executive Officer, Director

Avanos Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avanos Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.